ArticleThe Journal of dermatology2024

Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study.

Mamitaro Ohtsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.